✦ LIBER ✦

Phase II Study of 96-hr Continuous-Infusion Etoposide and Doxorubicin with Bolus Cyclophosphamide in Refractory Epithelial Ovarian Cancer

✍ Scribed by Gini F. Fleming; Steven E. Waggoner; Jacob Rotmensch; Linda A. Skoog; Carole Langhauser

Book ID: 115617132
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 104 KB
Volume: 65
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1997.4622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of 96-hr continuous-infus

Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer: Fleming G.F.; Waggoner S.E.; Rotmensch J.; Skoog L.A.; Langhauser C. USA Gynecol Oncol 1997 65/1 (42–45)

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 127 KB

A phase II and pharmacodynamic study of

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d

Phase II trial of high-dose intravenous

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

✍ Morgan, R J; Doroshow, J H; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasa 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

Phase 2 study of canfosfamide in combina

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

✍ John J Kavanagh; Charles F Levenback; Pedro T Ramirez; Judith L Wolf; Carla L Mo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 404 KB

A phase I/II study of continuous infusio

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response

✍ C. J. Bowden; W. D. Figg; N. A. Dawson; O. Sartor; R. J. Bitton; M. S. Weinberge 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 156 KB

Phase I/II and pharmacologic study of lo

Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB